ÂÜÀòÂÒÂ×

Vincent Brichard is a distinguished professional in the field of oncology and immunotherapy, currently serving as the Senior Vice-President at GlaxoSmithKline Biologicals since March 2002, where Vincent leads the Immunotherapeutics Business Units, focusing on antigen-specific cancer immunotherapy and therapeutic vaccines. Prior to this role, Vincent worked at the Louvain University Medical Oncology Unit from September 2000 to March 2002 as an oncologist specializing in tumor immunology, and at Institut Curie in the Medical Oncology Department from July 1998 to September 2000. Vincent holds a medical degree in oncology from Université catholique de Louvain, obtained between 1986 and 1990.